Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Cynomolgus IL2RA, LEVLFQ tagged

Cat.No. : IL2RA-135C
Product Overview : Recombinant Cynomolgus IL2RA (H6WS54) (Met1-Arg213), fused with six amino acids (LEVLFQ) at the C-terminus, was produced in Human Cells.
  • Specification
  • Gene Information
  • Related Products
Source : Human Cells
Species : Cynomolgus
Tag : LEVLFQ
Predicted N Terminal : Glu 22
Form : Lyophilized from sterile PBS, pH 7.4.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
Molecular Mass : The recombinant cynomolgus IL2RA comprises 199 amino acids and has a calculated molecular mass of 22.4 KDa.The apparent molecular mass of the protein is approximately 38-42 KDa respectively in SDS-PAGE.
Endotoxin : < 1.0 eu per μg of the protein as determined by the LAL method.
Purity : >95 % as determined by SDS-PAGE
Stability : Samples are stable for up to twelve months from date of receipt at -70oC.
Storage : Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution : It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents.
Gene Name : IL2RA?interleukin 2 receptor, alpha [?Macaca fascicularis?(crab-eating macaque) ]
Official Symbol : IL2RA
Gene ID : 102123605
mRNA Refseq : NM_001283704
Protein Refseq : NP_001270633
Chromosome Location : 9

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (6)

Ask a question
Is there any adverse effect of IL2RA combined with other drugs? 12/10/2022

The combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.

How often is IL2RA used? 01/11/2022

The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.

Whether there is an effect of IL2RA? 12/17/2021

IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.

Can IL2RA treat cancer? 05/18/2021

Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.

How effective is IL2RA treatment? 04/07/2020

The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.

What are the indications for IL2RA? 01/09/2020

Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.

Customer Reviews (3)

Write a review
Reviews
09/29/2022

    Security is very high and can be used with confidence.

    06/05/2021

      Structure is very stable and not prone to mutation.

      03/14/2019

        The amount of expression is very high and can be easily detected.

        Ask a Question for All IL2RA Products

        Required fields are marked with *

        My Review for All IL2RA Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends